Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study

Bibliographic Details
Main Authors: Velenik, Vaneja, Ocvirk, Janja, Music, Maja, Bracko, Matej, Anderluh, Franc, Oblak, Irena, Edhemovic, Ibrahim, Brecelj, Erik, Kropivnik, Mateja, Omejc, Mirko
Format: Online
Language:English
Published: BioMed Central 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179720/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179720/

Similar Items